Home » Topics » Briefs » Regulatory actions

Regulatory actions
RSS

Regulatory actions for Oct. 10, 2019

Oct. 11, 2019

Regulatory actions Oct. 1-7, 2019

Oct. 9, 2019

Regulatory actions Sept. 24-30, 2019

Oct. 2, 2019

Regulatory front

Sep. 30, 2019

Product regulatory actions for Sept. 26, 2019

Sep. 27, 2019

Product regulatory actions for Sept. 25, 2019

Sep. 26, 2019

Regulatory actions Sept. 10-16, 2019

Sep. 18, 2019

Regulatory actions for July 30, 2019

July 31, 2019

Regulatory actions for July 29, 2019

July 30, 2019

Regulatory actions for July 26, 2019

July 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 11, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 11, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.